DARE · Dare Bioscience, Inc.
$1.28
+0.02 (+1.59%)
At close · Jul 24
Market Cap
$19.17M
Shares
14.98M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-24 | — | |
| 8-K | 2026-07-17 | 2026-07-13 | |
| 8-K | 2026-07-13 | — | |
| 8-K | 2026-06-22 | — | |
| 8-K | 2026-06-12 | 2026-06-11 | |
| 8-K | 2026-05-18 | 2026-05-14 | |
| 8-K | 2026-05-14 | — | |
| 10-Q | 2026-05-14 | 2026-03-31 | |
| 8-K | 2026-05-07 | 2026-05-01 | |
| DEF 14A | 2026-04-28 | 2026-06-11 | |
| 8-K | 2026-04-22 | — | |
| 8-K | 2026-04-20 | 2026-04-17 | |
| 8-K | 2026-04-17 | 2026-04-16 | |
| 8-K | 2026-04-13 | 2026-04-10 | |
| 8-K | 2026-03-26 | — | |
| 10-K | 2026-03-26 | 2025-12-31 | |
| 8-K | 2026-03-17 | 2026-03-16 | |
| 8-K | 2026-03-09 | 2026-03-06 | |
| 8-K | 2026-03-02 | — | |
| 8-K | 2026-01-29 | 2026-01-23 | |
| 8-K | 2026-01-06 | — | |
| 8-K | 2025-12-01 | 2025-11-26 | |
| 10-Q | 2025-11-13 | 2025-09-30 | |
| 8-K | 2025-11-13 | — | |
| 8-K | 2025-09-02 | — | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K | 2025-08-14 | — | |
| 8-K | 2025-07-25 | — | |
| 8-K | 2025-07-21 | 2025-07-18 | |
| 8-K | 2025-07-14 | — | |
| 8-K | 2025-07-09 | — | |
| 8-K | 2025-06-25 | — | |
| 8-K | 2025-06-09 | — | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| 8-K | 2025-05-13 | — | |
| DEF 14A | 2025-04-24 | 2025-06-12 | |
| 8-K | 2025-04-11 | — | |
| 8-K | 2025-03-31 | — | |
| 10-K | 2025-03-31 | 2024-12-31 | |
| 8-K | 2025-02-14 | 2025-02-13 | |
| 8-K | 2025-02-10 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-12-16 | — | |
| 8-K | 2024-11-14 | — | |
| 10-Q | 2024-11-14 | 2024-09-30 | |
| 8-K | 2024-10-25 | — | |
| 8-K | 2024-10-23 | — | |
| 8-K | 2024-10-21 | — | |
| 10-Q | 2024-08-12 | 2024-06-30 | |
| 8-K | 2024-08-12 | — |
Showing 1–50 of 162 filings